Variants in estrogen-biosynthesis genes CYP17 and CYP19 and breast cancer risk: a family-based genetic association study

Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA.
Breast cancer research: BCR (Impact Factor: 5.88). 01/2005; 7(1):R71-81. DOI: 10.1186/bcr951
Source: PubMed

ABSTRACT Case-control studies have reported inconsistent results concerning breast cancer risk and polymorphisms in genes that control endogenous estrogen biosynthesis. We report findings from the first family-based association study examining associations between female breast cancer risk and polymorphisms in two key estrogen-biosynthesis genes CYP17 (T-->C promoter polymorphism) and CYP19 (TTTA repeat polymorphism).
We conducted the study among 278 nuclear families containing one or more daughters with breast cancer, with a total of 1123 family members (702 with available constitutional DNA and questionnaire data and 421 without them). These nuclear families were selected from breast cancer families participating in the Metropolitan New York Registry, one of the six centers of the National Cancer Institute's Breast Cancer Family Registry. We used likelihood-based statistical methods to examine allelic associations.
We found the CYP19 allele with 11 TTTA repeats to be associated with breast cancer risk in these families. We also found that maternal (but not paternal) carrier status of CYP19 alleles with 11 repeats tended to be associated with breast cancer risk in daughters (independently of the daughters' own genotype), suggesting a possible in utero effect of CYP19. We found no association of a woman's breast cancer risk either with her own or with her mother's CYP17 genotype.
This family-based study indicates that a woman's personal and maternal carrier status of CYP19 11 TTTA repeat allele might be related to increased breast cancer risk. However, because this is the first study to report an association between CYP19 11 TTTA repeat allele and breast cancer, and because multiple comparisons have been made, the associations should be interpreted with caution and need confirmation in future family-based studies.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Breast cancer is the leading cause of death among women in developing countries. In Portugal, it presents the highest incidence and mortality rates in women diseases. About 10% of breast cancer is inherited, presenting a family pattern of incidence, and have been attributable to mutations in high penetrance susceptibility genes, such as BRCA1 and BRCA2. However, BRCA1 and BRCA2 mutations account only for around 25% of families with inherited breast cancer. Many environmental factors have been associated with risk of breast cancer development, such as ionized radiation, chemical carcinogens (diet and environment). These mutagens sources, together with endogenous and exogenous estrogens, produce a range of DNA lesions such as reactive oxygen species, oxidized bases, bulky DNA adducts and DNA strand breaks. Therefore, DNA repair capacity determines cellular susceptibility to endogenous and exogenous substances and factors. The response of cells to DNA damage and their ability to maintain genomic instability by DNA repair are crucial in preventing cancer initiation and progression. Some studies have demonstrated a strong association of higher levels of DNA damage and lower DNA repair capacity in breast cancer patients and healthy women with a positive family history of breast cancer. Several polymorphisms have been described in DNA signalling and repair genes. Therefore, although each polymorphism may be associated with a small increased risk for breast cancer in an individual, the risk attributable in the population as a whole is likely to be higher than for rare, high-penetrance susceptibility genes. In this review, we intend to illustrate the state of the art in studies concerning DNA signalling or repair genetic polymorphisms and breast cancer susceptibility.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Polycystic ovary syndrome (PCOS) is a heterogeneous disease with a strong genetic origin, but the specific determinants are still unknown. The aim of this study was to investigate the association between the (TTTA) n polymorphism in intron 4 of CYP19 and the PCOS risk in a Chinese population. We performed a case-control study which involved 222 PCOS patients and 281 controls. The fluorescent-labeled target DNA fragments containing the (TTTA) n short tandem repeats were obtained by PCR, thereafter genotyped via capillary electrophoresis. Representative alleles were directly sequenced to confirm their repeat numbers. Genotype analysis revealed seven different alleles including 7-3(∆)-, 7-, 8-, 10-, 11-, 12- and 13-TTTA-repeats. The most common allele in a Chinese population is (TTTA) 11 in our study (0.354 for PCOS and 0.390 for controls). PCOS patients showed a higher frequency of short alleles compared with controls (0.47 vs. 0.41, OR = 1.245, 95 % CI 0.97-1.60). The overall allelic distributions of this polymorphism did not show any significant differences between PCOS patients and the control group. No statistical differences were found in the clinical parameters or serum steroid hormone levels among PCOS patients with different genotypes. In conclusion, PCOS patients had a higher frequency of short alleles, albeit this might not strongly affect the risk of PCOS.
    Molecular Biology Reports 05/2013; 40(8). DOI:10.1007/s11033-013-2605-4 · 1.96 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Microstructure of the organo-modified SBA-15(vinyl SBA-15) prepared under different pH was investigated using a scanning electron microscopy(SEM). It was found that the morphology of the organo-modified mesoporous materials depended on pH conditions during sol-gel reaction. The periodic mesoporous structure was formed when the materials are obtained in rod-like shapes.

Full-text (3 Sources)

Available from
May 21, 2014